期刊文献+

E型沙眼衣原体MOMP基因重组质粒的构建与表达 被引量:2

Construction and expression of recombiant eukaryotic plasmid of the majer outer membrane protein from Chlamydia trachomatis seovar E
下载PDF
导出
摘要 目的:构建E型沙眼衣原体(Ct)主要外膜蛋白(MOMP)基因重组真核表达质粒pVAX1-MOMP,为探索安全的E型CtDNA疫苗奠定基础。方法:根据Genebank中E型CtMOMP基因序列设计引物,用高保真PCR方法从E型Ct基因组DNA中扩增得到约1.1kb的MOMP片段,克隆至pcDNAII载体,测序后亚克隆至表达载体pVAX1,构建卡那霉素抗性真核重组表达质粒pVAX1-MOMP,并以重组质粒转染COS-1细胞进行表达,用Westernblotting方法鉴定表达产物。结果:从E型Ct基因组DNA中扩增出特异的MOMP基因片段,酶切鉴定及DNA序列测定证实pVAX1-MOMP重组质粒构建正确,能在COS-1细胞内表达,表达产物能与抗MOMP单克隆抗体特异性结合。结论:成功构建E型沙眼衣原体MOMP真核表达质粒pVAX1-MOMP,并在真核细胞内获得表达。 Objective: To construct a recombiant eukaryotic expression plasmid pVAX1-MOMP carrying the major outer membrane protein (MOMP) gene of Chlamydia trachomatis serovar E, make an expression of MOMP gene and study the antigenicity of the expressed product. Methods: The MOMP gene fragments of Chlamydia trachomatis serovar E were amplified from genome DNA by PCR method. They were cloned into pcDNAⅡ vector and subcloneded into the vector pVAX1 to construct the recombiant eukaryotic expression plasmid pVAX1-MOMP. The recombinant expression plasmids were transfected into COS-1 cells. The expression of MOMP protein was detected by Western blotting. Results: 1.1 kb gene fragments was amplified from genome DNA by PCR method as anticipated. Recombinant plasmids were confirmed by enzyme digestion and nucleotide sequencing, and MOMP proteins were detected in COS-1 cells. Conclusion: Recombinant plasmids have been successfully constructed. MOMP gene can be expressed in COS-1 cells.
出处 《山东大学学报(医学版)》 CAS 北大核心 2005年第11期985-988,共4页 Journal of Shandong University:Health Sciences
基金 国家自然科学基金资助项目(30271193) 国家自然科学基金对外交流与合作项目(30310403165) 山东省自然科学基金资助项目(Y2002004)
关键词 衣原体 沙眼 基因表达 基因 MOMP Chlamydia trachomatis Gene expression Genes, MOMP
  • 相关文献

参考文献2

二级参考文献8

共引文献10

同被引文献16

  • 1李忠玉,吴移谋,余敏君,陈超群.沙眼衣原体主要外膜蛋白核酸疫苗诱导小鼠产生特异性细胞和体液免疫应答(英文)[J].免疫学杂志,2005,21(6):457-459. 被引量:2
  • 2Zhang D, Yang X, Berry J, et al. DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection. J Infect Dis, 1997, 176(4):1035-1040.
  • 3Pal S, Peterson EM, Rappuoli R, et al. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge. Vaccine, 2006, 24 (6): 766-775.
  • 4Pal S, Barnhart KM, Wei Q, et al. Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge.Vaccine, 1999, 17(5): 459-465.
  • 5Brunham RC, Rappuoli R. Chlamydia trachomatis control requires a vaccine. Vaccine, 2013, 31(15) : 1892-1897.
  • 6Pal S, Bamhart KM, Wei Q, et al. Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer mem- brane protein elicits an immune response but fails to protect against a genital challenge. Vaccine. 1999. 17(5) : 459-465.
  • 7Lti H, Wang H, Zhao HM, et ah Dendritic cells (DCs) trans- fected with a recombinant adenovirus carrying chlamydial major outer membrane protein antigen elicit protective immune responses against genital tract challenge infection. Biochem Cell Biol, 2010, 88(4) : 757-765.
  • 8Yang Y, Yang X, Gu Y, et al. Protective immune response in- duced by co-immunization with the Trichinella spiralis recombinant Ts87 protein and a Ts87 DNA vaccine. Vet Parasitol, 2013, 194 (2-4) : 207-210.
  • 9Howie SE, Homer PJ, Home AW, et al. Immunity and vaccines against sexually transmitted Chlamydia trachomatis infection. Curr Opin Infect Dis, 2011,24(1) : 56-61.
  • 10Marks E, Tam MA, Lycke NY. The female lower genital tract is a privileged compartment with IL-IO producing dendritic cells and poor Thl immunity following Chlamydia trachomatis infection. PLoS Pathog, 2010, 6(11) : e1001179.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部